Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer

Bookmark and Share
Published: 18 Dec 2019
Views: 444
Prof Jack Cuzick - Queen Mary University of London, London, UK

Prof Jack Cuzick speaks to ecancer at the 2019 San Antonio Breast Cancer Symposium about the preventative effects of anastrozole in post-menopausal, high-risk women.

He explains the rationale behind this study, which has achieved a 60 percent reduction of breast cancer incidence in the first five years and an additional 36 percent after every subsequent year.

Prof Cuzick also notes that this long-term follow up shows the effectiveness of anastrozole over tamoxifen.

He also discusses how patients were stratified as "high-risk", associated adverse effects and the possibility of investigating mortality in the future.

Watch the press conference here.

Read more about the study here